Neutrogena T/Sal

Manufacturer
Johnson & Johnson Consumer Inc.
Effective date
2021-05-20
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
legacy-cache
Hydrated at
2026-08-01 22:44:36

Label at a glance#

ProductNeutrogena T/Sal Therapeutic
Active ingredientSALICYLIC ACID
Label structure10 sections

Dosage and administration

For best results, use at least twice a week or as directed by a physician Wet hair thoroughly Massage liberal amount of shampoo into the scalp Leave lather on scalp for several minutes Rinse and repeat

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 3.0%

Purpose

OTC - PURPOSE SECTION

Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis

Use

INDICATIONS & USAGE SECTION

Controls the symptoms of dandruff, seborrheic dermatitis and psoriasis.

Warnings

WARNINGS SECTION

For external use only

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have a condition that covers a large area of the body.

OTC - WHEN USING SECTION

When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • For best results, use at least twice a week or as directed by a physician
  • Wet hair thoroughly
  • Massage liberal amount of shampoo into the scalp
  • Leave lather on scalp for several minutes
  • Rinse and repeat

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water
Cocamidopropyl Betaine
Sodium C14-16 Olefin Sulfonate
Linoleamidopropyl PG-Dimonium Chloride Phosphate
Sodium Lauroyl Sarcosinate
Polyquaternium-22
Hexylene Glycol
Sodium Citrate

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-877-256-4247 (USA only). For more information go to: www.tgel.com

SPL UNCLASSIFIED SECTION

© Dist. by Neutrogena Corporation
Los Angeles, CA 90045

PRINCIPAL DISPLAY PANEL - 133 mL Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Neutrogena ®
T/SAL ®
therapeutic
shampoo

Scalp Build-Up
Control

clears and helps
prevent flakes and
scalp build-up

  • starts working after
    just one use
  • dandruff, psoriasis,
    seborrheic dermatitis

#1 DERMATOLOGIST
RECOMMENDED BRAND

NEUTROGENA ®

3% SALICYLIC ACID
4.5 FL OZ (133mL)

PRINCIPAL DISPLAY PANEL - 133 mL Carton
PRINCIPAL DISPLAY PANEL - 133 mL Carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Salicylic AcidACTIVE INGREDIENTO414PZ4LPZ1
Salicylic AcidACTIVE MOIETYO414PZ4LPZ1
Cocamidopropyl BetaineINACTIVE INGREDIENT5OCF3O11KX1
Hexylene GlycolINACTIVE INGREDIENTKEH0A3F75J1
Linoleamidopropyl PG-Dimonium Chloride PhosphateINACTIVE INGREDIENT5Q87K461JO1
Sodium C14-16 Olefin SulfonateINACTIVE INGREDIENTO9W3D3YF5U1
Sodium CitrateINACTIVE INGREDIENT1Q73Q2JULR1
Sodium Lauroyl SarcosinateINACTIVE INGREDIENT632GS996181
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10812-91610812-916-02, 10812-916-01, 10812-916-67

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 6 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Hexylene GlycolHEXYLENE GLYCOLKEH0A3F75JSOLUTION / TOPICAL0.3 %w/wExact identifier — unii candidate
4 equally ranked IID candidates
Sodium Lauroyl SarcosinateSODIUM LAUROYL SARCOSINATE632GS99618LOTION / TOPICAL70 mgExact identifier — unii candidate
2 equally ranked IID candidates
Hexylene GlycolHEXYLENE GLYCOLKEH0A3F75JOINTMENT / TOPICAL12 %w/wExact identifier — unii candidate
4 equally ranked IID candidates
Sodium Lauroyl SarcosinateSODIUM LAUROYL SARCOSINATE632GS99618SHAMPOO / TOPICAL12.5 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
Hexylene GlycolHEXYLENE GLYCOLKEH0A3F75JCREAM / TOPICAL385 mgExact identifier — unii candidate
4 equally ranked IID candidates
Hexylene GlycolHEXYLENE GLYCOLKEH0A3F75JGEL / TOPICAL280 mgExact identifier — unii candidate
4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c2c148c3-b2e0-46a7-e053-2995a90a6135c67a7d3f-1aff-4753-a64a-d06618e2ddda2021-05-20WarningsExact identifier
spl id: c2c148c3-b2e0-46a7-e053-2995a90a6135
spl set id: c67a7d3f-1aff-4753-a64a-d06618e2ddda

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.